Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective

Canadian Journal of Infectious Diseases

Volumn 8, Issue 4, 1997, Pages 202-208

  Marra, Fawziah ^a   Marra, Carlo A ^b   Patrick, David M ^b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

Azithromycin; Chlamydia trachomatis; Doxycycline; Pharmacoeconomics

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PELVIS PAIN SYNDROME; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030986522     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/870203     Document Type: Article

References (35)

1. Health and Welfare Canada. Canadian guidelines for the prevention, diagnosis, management, and treatment of sexually transmitted diseases in neonates, children, adolescents and adults. Ottawa: Health and Welfare Canada, 1995.
2. Sexually transmitted disease control 1994 Annual Report. Victoria: BC Ministry of Health and Ministry Responsible For Seniors, 1995.
3. Bowie W, Holmes K. Chlamydial diseases. In: Mandell G, Douglas R, Bennett J, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1990:1424-31.
4. Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987;257:2070-2.
5. Bowie WR. Drug therapies for sexually transmitted diseases: clinical and economic considerations. Drugs 1995;49:496-515.
6. Hillis S, Black C, Newhall J, Walsh C, Groseclose SL. New opportunities for chlamydia prevention: Applications of science to public health practice. Sex Transm Dis 1995;22:197-202.
7. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992;327:921-5.
8. Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of the nongonococcal syndrome in men. JAMA 1995;274:545-9.
9. Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Single dose azithromycin treatment of gonorrhea and infections caused by C trachomatis and U urealyticum in men. Sex Transm Dis 1994;21:43-6.
10. Ossewaarde JM, Plantema FH, Rieffe M, et al. Efficacy of single dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol 1992;11:693-6.
11. Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993;122:961-5.
12. Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Agents Chemother 1990;25(Suppl A):109-14.
13. Haddix AC, Hillis SD, Kassler WJ. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Transm Dis 1995;22:274-80.
14. Stamm WE. Problems in the treatment of bacterial sexually transmitted disease. Am J Med 1987;82(Suppl 4A):307-10.
15. Jordan WC. Doxycycline vs tetracycline in the treatment of men with gonorrhea: the compliance factor. Sex Transm Dis 1981;8(Suppl):S105-9.
16. Katz BP, Zwickl BW, Caine VA, et al. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 1992;19:351-9.
17. Brookoff D. Compliance with outpatient antibiotics among women treated in the emergency department for pelvic inflammatory disease. Ann Emerg Med 1992;21:621.
18. Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980;138:1042-7.
19. Paton DL, Askienazy-Elbhar BD, Henry-Suchet J, et al. Detection of Chlamydia trachomatis in fallopian tissue in women with post-infectious tubal infertility. Am J Obstet Gynecol 1994;171:95-101.
20. Cates W, Joesoef MR, Goldman MB. Atypical pelvic inflammatory disease: Can we identify the clinical predictors? Am J Obstet Gynecol 1993;169:341-6.
21. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR 1993;42(RR-12):1-39.
22. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984;310:545-9.
23. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138:880-91.
24. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopy. Sex Transm Dis 1992;19:185-92.
25. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707-13.
26. Washington AE, Sweet RL, Shafer MA. Pelvic inflammatory disease and its sequelae in adolescents. J Adolesc Health Care 1985;6:298-310.
27. Svensson L, Mardh PA, Westrom L. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril 1983;40:322-9.
28. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA 1991;266:2565-9.
29. Jones RB, Mammel JB, Shepard M, et al. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol 1986;155:35-9.
30. Washington AE, Arno PS, Brooks MA. The economic cost of pelvic inflammatory disease. JAMA 1986;255:1735-8.
31. Washington AE, Cates W Jr, Zaidi AA. Hospitalizations for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981. JAMA 1984;251:2529-33.
32. BC Medical Association Guide to Fees. Vancouver: BC Medical Association, 1995.
33. Magid D, Douglas JM Jr, Schwartz S. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996;124:389-99.
34. Nuovo J, Melnikow J, Paliescheskey M, et al. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis. J Am Board Fam Practice 1995;8:7-16.
35. Genç M, Mårdh PA. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124;1-7.